Assessment of patients' preferences regarding the characteristics associated with the treatment of chronic obstructive pulmonary disease

Emel Bulcun, Mehmet Ekici, Aydanur Ekici, Emel Bulcun, Mehmet Ekici, Aydanur Ekici

Abstract

Objective: Patient preferences regarding characteristics associated with the treatment of chronic obstructive pulmonary disease (COPD) must be determined to increase the compatibility between the patients and the treatments, but as yet no studies have been performed regarding these characteristics. Here, we evaluate the preferred characteristics associated with the treatment of patients with COPD.

Method: The expectations of patients receiving copd therapy were assessed in six categories: time allocated by the physician to listen to patients' complaints, treatment to be applied, estimated adverse effect frequency concerning the therapy, ability of patients to visit the same physician each time, integral approach of the physician to the treatment of the patient, and therapy cost. These groups were divided into categories of therapy indicating 25 alternative treatment methods, using conjoint analysis. Patients were sorted to the 25 types of treatment with regard to their preferences.

Results: The major expectation of conjoint analysis associated with the treatment of COPD patients is for the therapy to allow the patients to completely recover from their complaints. The order preferred by patients of other treatment expectations is from sufficient time to be allowed by the physician to listen to the patient, to no cost for the treatment, to minimum adverse effects resulting from the treatment, to each follow-up to be performed by the same physician, and to the physician performing an assessment of the patient's well-being, rather than examining only the areas of complaint.

Conclusion: The major expectation of COPD patients regarding treatment was to completely recover with the help of the therapy. Considering the expectations of the patient may help improve the compatibility of the patient with the treatment.

Keywords: COPD; conjoint analysis; preferences of treatment.

References

    1. Edworthy SM, Devins GM. Improving medication adherence through patient education distinguishing between appropriate and inappropriate utilization. Patient Education Study Group. J Rheumatol. 1999;26(8):1793–1801.
    1. Daltroy LH. Doctor-patient communication in rheumatological disorders. Baillieres Clin Rheumatol. 1993;7(2):221–239.
    1. Ryan M, McIntosh E, Shackley P. Methodological issues in the application of conjoint analysis in health care. Health Econ. 1998;7(4):373–378.
    1. Sweileh WM, Ihbesheh MS, Jarar IS, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav. 2011;21(3):301–305.
    1. Osman LM, McKenzie L, Cairns J, et al. Patient weighting of importance of asthma symptoms. Thorax. 2001;56(2):138–142.
    1. Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Colehan J, Partridge M. Assessing patients’ preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax. 2002;57(6):503–508.
    1. Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet] 2011. [Accessed March 25, 2013]. Available from: .
    1. Standardization of spirometry – 1987 update Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136(5):1285–1298.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
    1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
    1. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
    1. Ardelean DL, Iulia L, Popescu R, et al. Evaluation of COPD patients using CAT-COPD assessment test. Pneumologia. 2012;61(4):221–229.
    1. Johansson G, Ställberg B, Tornling G, et al. Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest. 2004;125(3):916–923.
    1. Bryan S, Buxton M, Sheldon R, Grant A. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ. 1998;7(7):595–603.
    1. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med. 1999;48(4):535–546.
    1. Korsch BM, Negrete VF. Doctor-patient communication. Sci Am. 1972;227(2):66–74.
    1. Cakmak G, Saglam ZA, Saler T, Yenigun M, Temiz LU. Socio-economic status of smokers presenting to the outpatient service: does chronic obstructive pulmonary disease make a difference? Indian J Chest Dis Allied Sci. 2012;54(1):19–22.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever